Novel Ophthalmic Drug Delivery


Anatomy and physiology of the eye protect it from damage. It therefore minimizes the transport of medication by traditional dosage forms to the eye, and the therapeutic concentration of drugs may not be maintained for long periods of time. Ocular drug delivery systems allowed for long-term treatment of ocular infections by delivering medication directly to the anterior segment of the eye. For the treatment of chronic vitreoretinal diseases, different biodegradable or non-biodegradable polymer implants have been widely investigated. Developing ocular drug delivery systems that provide controlled release of medication can reduce the dosing frequency for chronic diseases.


  • Nanoparticles
  • Drug embedded contact lenses
  • Iontophorosis

Related Conference of Novel Ophthalmic Drug Delivery

January 26-27, 2026

3rd Global Summit on Geriatrics & Aging

Paris, France
March 09-10, 2026

9th World Congress on Surgeons

Singapore City, Singapore
March 09-10, 2026

12th International Conference on Surgeons

Singapore City, Singapore
May 14-15, 2026

6th World Congress on Surgery

London, UK
September 14-15, 2026

12th European Otolaryngology-ENT Surgery Conference

Rome, Italy

Novel Ophthalmic Drug Delivery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in